heart disease | Science and Enterprise

When even PhRMA doesn't want to be a Trump campaign prop ... A Deal on Drug Prices Undone by White House Insistence… https://t.co/JjdVxOTVV6
about 16 hours ago
A company developing a drug for depression based on synthesized compounds in hallucinogenic substances is raising $… https://t.co/D8kwt0ng5X
about 17 hours ago
New post on Science and Enterprise: Mental Health Drug Company Raises $127.5M in IPO https://t.co/39Xea7VQpV #Science #Business
about 17 hours ago
A test for SARS-CoV-2 viruses is shown in field tests to return diagnostic results in 90 minutes with accuracy comp… https://t.co/EuQIPTsL57
about 20 hours ago
New post on Science and Enterprise: Point-of-Care Covid-19 Diagnostic Shows High Accuracy https://t.co/4l3pGrHx2o #Science #Business
about 20 hours ago

Phone Camera, A.I. Detect Early Diabetes

By Alan, on August 18th, 2020%

Researchers devised techniques with a smartphone app, and data analyzed with artificial intelligence, to identify people in early stages of type 2 diabetes. . . . → Read More: Phone Camera, A.I. Detect Early Diabetes

Women’s Heart Health Diagnostics in the Works

By Alan, on August 14th, 2020%

An organization for redressing health disparities faced by women awarded a new grant to advance better tools for predicting risk of women’s heart disease. . . . → Read More: Women’s Heart Health Diagnostics in the Works

Crispr Heart Therapy Demonstrated in Monkeys

By Alan, on June 29th, 2020%

An experimental therapy using a precise gene editing technique is shown in lab monkeys to reverse the cause of a chronic form of heart disease. . . . → Read More: Crispr Heart Therapy Demonstrated in Monkeys

Convalescent Plasma Found Safe as Covid-19 Therapy

By Alan, on June 19th, 2020%

Donated blood plasma from people who recovered from Covid-19 infections is found to cause few serious side effects when given as a treatment for infections in others. . . . → Read More: Convalescent Plasma Found Safe as Covid-19 Therapy

Crispr Heart Disease Start-Up Raises New $63M

By Alan, on June 11th, 2020%

A one year-old company developing a one-time gene-editing treatment for coronary artery disease is adding $63 million to its first venture funding round. . . . → Read More: Crispr Heart Disease Start-Up Raises New $63M

Mayo Clinic, A.I. Company Study Covid-19 Heart Disease

By Alan, on May 12th, 2020%

A developer of software to diagnose heart disease from images with artificial intelligence is assessing Covid-19 infection patients for heart ailments with the Mayo Clinic. . . . → Read More: Mayo Clinic, A.I. Company Study Covid-19 Heart Disease

Digital Health Research Platform Set for Covid-19

By Alan, on April 20th, 2020%

A group of medical technology companies are forming a research platform and registry for clinical trials of Covid-19 treatments among home-bound participants. . . . → Read More: Digital Health Research Platform Set for Covid-19

Wearable Defibrillator Maker Gains $145.6M

By Alan, on March 4th, 2020%

The developer of a patch device that monitors and adjusts heart rhythms to prevent sudden cardiac death is raising $145.6 million in a new venture funds. . . . → Read More: Wearable Defibrillator Maker Gains $145.6M

A.I. Heart Ultrasound Software Cleared by FDA

By Alan, on February 10th, 2020%

Software guided by algorithms that capture top-quality ultrasound images of the heart is now authorized by the Food and Drug Administration. . . . → Read More: A.I. Heart Ultrasound Software Cleared by FDA

Incubator Seeks Heart, Lung, Blood Device Entrepreneurs

By Alan, on February 7th, 2020%

A business incubator in Massachusetts is seeking entrepreneurs and their companies developing medical devices for heart, lung, blood, and sleep disorders. . . . → Read More: Incubator Seeks Heart, Lung, Blood Device Entrepreneurs

Science & Enterprise subscription

Specials

Follow us on Twitter

Guest Posts

Please share Science & Enterprise